Introduction
Osteoarthritis (OA) is the most prevalent joint disease with the typifying feature being the progressive degradation of articular cartilage during disease progression. OA affects over 4 million people in the UK with around 60% of those over the age of 60 showing signs of the disease 1 . Although loss of cartilage is characteristic of OA, the disease also involves pathological changes to ligaments, capsular tissue, periarticular muscle, nerve, subchondral bone, meniscus and the synovium 2, 3 . However, data show that OA progression can be slowed by preventing cartilage degradation, a mechanism presumably mediated by the only cell type of cartilage, the chondrocyte 4 . A detailed examination of the molecular changes occurring in chondrocytes, and therefore cartilage, during disease development is critical to further our understanding of OA. Articular cartilage is composed predominately of an extracellular matrix (ECM) containing proteoglycan (principally aggrecan) and collagen (mainly type II). Turnover and remodeling of the cartilage ECM is a normal physiological process mediated through the regulation of the expression of matrix components and matrixdegrading enzymes by the chondrocyte 4 . In OA the chondrocyte phenotype alters, through as yet unidentified processes, such that gene expression changes occur which mean the homeostatic balance between anabolism and catabolism is lost in favor of the latter. In terms of ECM catabolism, type II collagen is cleaved by matrix metalloproteinases (MMPs), with MMP-13 the generally accepted collagenase in OA. Pathological aggrecan cleavage is by 'A disintegrin and metalloproteinase with thrombospondin motifs' (ADAMTS) enzymes, most probably ADAMTS-5 5 . Loss of aggrecan from cartilage is reversible whilst collagen breakdown is not and therefore represents an irreversible step in cartilage degradation 6, 7 . As well as alterations in the expression of many proteases 8e10 , chondrocytes show altered expression of a number of proinflammatory cytokines [e.g., Interleukin (IL)-1], cell receptors (e.g., toll-like receptors), matrix proteins (type II and X collagens and aggrecan) and several transcription factors 11 which could further exacerbate the degradative phenotype.
Since the chondrocyte appears central to OA pathogenesis a complete knowledge of the genes differentially expressed in OA and normal articular cartilage is required. To date, such comparisons are few and often limited in terms of using small data sets or reliant on animal models 12e17 , although several studies have examined gene expression changes between damaged and intact cartilage within the same knee joint of OA patients 13, 16 . One of the first studies to compare human normal vs OA cartilage identified a decrease in expression of important oxidative defence genes especially SOD2 and SOD3
18 , a finding we recently verified 19 .
Although this initial study was limited due to the use of custommade cDNA arrays covering around only 4000 genes, a major finding was that OA cartilage with no overt or only modest damage had significantly different gene expression profiles from healthy tissue 18 .
The first cartilage comparative study to use commercially available microarrays compared gene expression changes within five OA and five normal human knee patient cartilage biopsy samples 20 . This identified 1423 genes as being significantly differentially expressed, many of which had not previously been associated with OA such as COL8A2 and COL14A1. Considering the differences of OA prevalence and severity between the sexes 21 it was somewhat surprising that with such a small mixed sex sample size this study identified a large number of significant changes. The small sample size could have led to more false positives and, unlike most high-throughput microarray experiments, the authors did not apply multiple test correction when calculating significant P-values. Herein, we used Illumina Human HT-12 V3 whole-genome expression arrays to profile the transcriptome of cartilage collected from femoral heads of nine OA and ten neck of femur fracture (NOF) patients, all of which were female. The aim of the study was to investigate the molecular changes of chondrocytes in hip OA to provide a comprehensive understanding of disease pathology via identification of the pathways involved. To our knowledge this is the first study to analyze gene expression changes in human hip OA at the whole-genome level.
Materials and methods

Cartilage sample collection
Human articular cartilage samples were obtained from consented patients undergoing joint replacement surgery due to either end-stage hip OA or intracapsular NOF with Ethical Committee approval from the Newcastle and North Tyneside Health Authority. NOF fracture patients had no previous history of OA. Joints were inspected macroscopically and scored using a scheme adapted from Noyes classification 22 to include the presence of osteophytes (Supplementary Table 1 ) by a blinded experienced orthopedic surgeon. This adaptation to the Noyes classification (which is commonly used for arthroscopic knee cartilage scoring) was necessary because there are currently no accepted classifications for the macroscopic scoring of hip cartilage 23 . Hip samples scoring 1 were considered normal (control) while those scoring !5 were classified as osteoarthritic. For all joints macroscopically normal cartilage was collected, in the OA patients avoiding areas of obvious fibrillation, snap frozen in liquid nitrogen within 2 h of surgery and stored at À80 C prior to RNA extraction. All cartilage was washed extensively in phosphate buffered saline (PBS) to avoid contamination.
RNA extraction
Cartilage samples were ground into powder and homogenized using Invitrogen TRIzol Ò Reagent (Life Technologies, Paisley, UK) prior to RNA purification using the Qiagen RNeasy Ò mini kit (Qiagen, Crawley, UK) essentially as previously described 9 . Quantity and quality of RNA samples were measured with a NanoDrop spectrophotometer (Thermo Fisher Scientific, MA, USA) and RNA integrity checked using an Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA). RNA samples with RNA Integrity Number (RIN) !7 were selected for whole-genome expression array experiments.
Gene expression profiling and analysis
Illumina whole-genome expression array Human HT-12 V3 (Illumina Inc., Illumina United Kingdom, Saffron Walden, UK) was used to profile gene expression of RNA samples according to the manufacturer's protocol. Raw expression data were analyzed using Agilent GeneSpring GX 11 (Agilent Technologies, Santa Clara, CA, USA). Raw data were normalized with a quantile algorithm 24 and the baseline was transformed to the median of all samples. Those probes with a flag value of 'Present' or 'Marginal' in !80% of either OA or NOF samples were selected for further analysis. R package Combat was used to adjust the data to remove any possible batch effect incurred during RNA preparation 25, 26 .
Functional and pathway analysis of differentially expressed genes
Gene Set Enrichment Analysis (GSEA) was used to investigate enriched functions of differentially expressed genes 27 . The differentially expressed gene list was ranked according to their fold changes and compared with sets of genes that were classified according to the gene ontologies for molecular function, cellular component and biological process 28 . Results with P-value 0.05 and false discovery rate (FDR) 0.25 were considered as significant. Ingenuity Pathway Analysis (IPA) (Ingenuity Systems, www. ingenuity.com) was used to identify canonical pathways associated with the differentially expressed genes. All of the differentially expressed genes were included in the analysis. P-values 0.05 were used to filter results.
Protein interaction network analysis
Protein interactions among up-and down-regulated genes in OA samples were analyzed with the use of the search tool STRING 29 . We used STRING with three data sources ('genomic context', 'highthroughput experiments' and 'co-expression') to detect and predict interactions between proteins. We did not include the data source 'previous knowledge' to derive results since these are data taken from text-mining and is therefore not determined experimentally. A gene with !five interactions with other genes was classified as a hub.
Real-time reverse-transcription polymerase chain reaction (RT-PCR)
To verify the microarray results, RNA (0.5 mg) from OA and NOF cartilage was reverse transcribed into cDNA using M-MLV reverse transcriptase (Life Technologies, Paisley, UK) as previously described 30 and gene expression determined using . Target gene expression was normalized to 18S expression levels using the calculation 2
ÀDCt .
Statistical analysis
From the microarray analysis significance of differentially expressed genes was evaluated with a ManneWhitney U test, which is nonparametric, and corrected for multiple testing using the BenjaminieHochberg 32 method. Differentially expressed genes with a fold change ! AE1.5 and P-value 0.01 were included in further analyses. Statistical analysis of differential expression between OA and NOF cartilage samples using real-time RT-PCR data also used the ManneWhitney U test where P-values < 0.05 (*) were considered significant. GSEA uses a permutation test procedure to evaluate the significance of gene ontology (GO) term enrichments. Because these P-values are not multiple testing corrected, a FDR (calculated as described 27 ) of 0.25 was used as threshold to control the number of false positives. The Fisher's exact test, implemented in IPA (Ingenuity Systems, www.ingenuity. com) and other pathway analysis applications 33 , was used to assess the significance of the association between a pathway and the differentially expressed genes. The Pearson product-moment correlation coefficient was used to test the correlation of fold changes of overlap genes between the Karlsson 20 and our study.
Results
Cartilage sample collection
In total 19 cartilage samples were collected from femoral heads of female OA donors (nine samples; median age ¼ 72 years), and female NOF donors (ten samples; median age ¼ 76 years). All donors were UK citizens of North European descent. The OA cartilage samples had obvious OA signs including degraded and fibrous cartilage with osteophytes and exposed subchondral bone. Compared to OA joints, the NOF femoral heads had fully intact cartilage with little fibrillation and no exposed bone ( Fig. 1A and B respectively). Macroscopic scoring, using an adaptation of the Noyes classification 22 , confirmed the two sample groups were significantly different (P 0.001) with OA samples having a mean score of 5.2 and NOF 0.6 (Supplementary Table 1 and Fig. 1C ). Following microarray analysis, unsupervised hierarchical clustering of cartilage samples based on expression of all genes passing the quality filter showed perfect segregation of the OA and NOF samples (Fig. 1D ).
Differentially expressed genes and functional analysis
In total we identified 998 differentially expressed genes (fold change À1.5 or ! þ1.5, P-value 0.01) between the two sample groups (shown in Supplementary Table 2 ). These included 465 upregulated and 533 down-regulated genes. Amongst these, 351 genes showed a !two-fold change of expression level. A number of these genes have previously been shown to be differentially expressed between hip OA and NOF cartilage including ADAMTS1, ADAMTS5, ADAMTS9, MMP1, MMP3, MMP23 and SOD2 8e10, 19 consistent with the data herein. The most robust downregulation was observed for chemokine ligand 20 (CCL20) which showed >22-fold less expression in the OA group. Within the most up-regulated genes are a number of collagen genes; COL2A1, COL5A2, COL9A1 and COL11A1, all of which have previously been reported to be up-regulated in OA cartilage 18 .
The predominant functions of up-and down-regulated genes within the three GO categories (molecular function, cellular component and biological process) were assessed (Table I; the genes  contributing to each enriched term are listed in Supplementary  Table 3 ). In terms of 'molecular function', the results indicate increased receptor activity and decreased oxidoreductase activity in OA cartilage. With regards to 'cellular components', ECM was enriched in the down-regulated gene lists. Although both up-and down-regulated genes lists contain approximately equal numbers of genes, those with reduced expression were classified into a far greater diversity of biological processes, such as stress responses, cell death and cellular processes. Of the up-regulated gene list within 'biological processes' all featured aspects of development, with in fact 'negative regulation of development' enriched in the down-regulated gene list.
Molecular pathway and protein interaction network analysis
The entire list of differentially expressed genes was found to be significantly (P 0.05) associated with 71 canonical pathways (Table II) , a number of which have previously been associated with OA 34e38 . Interestingly, the pathway analysis identified a possible role for IL-17 signaling in OA, generally based upon the altered expression of AKT3, IL8, mitogen-activated protein kinase (MAPK)1, MAPK10 and NFKB2. In all, six cancer signaling pathways showed a significant over-representation within the dataset. Within these cancer pathways a total of 58 genes were differentially expressed, with altered AKT3, CDKN1A, FZD2, FZD4, FZD7, FZD9, MAPK1, MAPK10, MYC, PDGFC and SMO expression providing a common link between the majority of these pathways. Network analysis was performed on all genes either up-or down-regulated in the OA tissue using STRING 29 . In total, nine upand 11 down-regulated genes were assigned as hubs (!five interactions) (Table III) . All these hubs were concentrated to four networks with a large network of 65 genes identified for the downregulated genes (Fig. 2) .
Real-time RT-PCR verification
Real-time RT-PCR was used to validate the expression levels of six genes identified as differentially expressed by the microarray study, three down-regulated (SOD2, NOD2/NLRC2 and CDKN1A) and three up-regulated (CAMK2G, COL2A1 and CTSK). After normalization to 18S expression all six genes were confirmed as significantly differentially expressed by both techniques with expression changes always in the predicted direction (Table IV) .
Comparison of knee vs hip OA gene expression
This is the first study to comprehensively investigate gene expression changes of hip OA cartilage. However, a similar study using knee OA vs normal cartilage has been reported 20 . In total, 1423 genes (1418 different genes including five duplicates) showed differential expression in the knee study, of which only 229 genes were also differentially expressed here ( Fig. 3A and Supplementary Table 4 ). In fact, of these overlapping genes, only 158 (11% of the 1418) showed regulation in the same direction although there was a significant positive correlation for such a trend ( Fig. 3B and C) . Genes that increased in both tissues with disease included a large number of collagens, including COL2A1, COL5A1, COL5A2, COL8A2, COL11A1, and COL13A1. Remarkably, given the small gene overlap, pathway analysis showed that 34 out of 71 canonical pathways associated with our gene list (P 0.05) are also associated with knee OA (Fig. 3D and Supplementary Table 5 ). Of these, 'Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis' and 'Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis' contained the largest number of overlapping differentially expressed genes. The 'Oncostatin M Signaling' pathway contained the highest ratio of differentially expressed genes (around 21% of all genes within that pathway).
Discussion
To our knowledge this is the first report to comprehensively relate gene expression changes in humans between normal (NOF) and OA hip cartilage at the whole-genome level. Several studies have compared gene changes using similar samples via a real-time RT-PCR technique but have generally focussed on specific genes, originally metalloproteinase family members 8, 9 , and more recently the entire degradome 10 . Although the datasets are different, reflecting the differences in techniques, all the proteases expressed differentially in both screens followed identical expression patterns in terms of direction (up-or downregulation), thus validating our samples and the microarray approach that we have taken here. We also confirmed the differential expression of six genes (three up-and three downregulated) from our microarray data using real-time RT-PCR, further validating the microarray platform. In total we found 998 genes differentially expressed with a fold change !1.5, in line with the only other whole-genome human cartilage study 20 . However, we found an almost equal number of genes were increased and decreased in the disease unlike the previous study which reported more genes with an increase in expression in knee OA cartilage 20 . Using functional enrichment analysis 'receptor activity' appeared up-regulated in OA. 'Oxidoreductase activity' was significantly down-regulated which is in keeping with a previous report that found a down-regulation of oxidative damage defence genes, including SOD2 and SOD3, in OA cartilage 18 , a finding we recently validated 19 . A decrease in oxidative defence/reductase activity would lead to an increase in reactive oxygen species and oxidative stress, a process that has been demonstrated in OA and shown to negatively affect chondrocyte function 39 . Our pathway analysis (IPA) identified several pathways based upon IL-17 or cancer signaling. Common to many of these were MAPK1 and AKT3. In fact these factors were also present in several other highlighted pathways and are pivotal components of phosphatidylinositol 3-kinase (PI3K)/Akt-signaling. We recently found that inhibition of Akt-signaling was chondroprotective and that depletion of AKT3, which is a serine/threonine kinase, in primary human articular chondrocytes reduced pro-inflammatory cytokine mediated induction of MMP-13, but not MMP-1 40 . In our screen AKT3 has reduced expression in OA, suggestive of an attempt to protect the remaining cartilage from further metalloproteinase-mediated destruction. The CC-chemokine, CCL20 (also known as MIP-3a) was the most down-regulated gene identified from our array and also appears to be an important target for IL-17 signaling 41 . CCL20 binds monogamously to the receptor CCR6 and interestingly signals via the Akt and/or ERK MAP Kinase pathway (see below). CCL20 acts as a chemoattractant for CCR6-expressing cells such as dendritic cells. There has been little research on CCL20 in OA pathogenesis but it has been suggested that it contributes to ECM-bone remodeling 42 .
However, in rheumatoid arthritis (RA), CCL20 produced by synovial cells is thought to play a pivotal role in the recruitment of arthritogenic Th17 (CD4 þ T cells that secrete IL-17A) cells to the inflamed joint 43 .
MAPK1 (ERK2) and MYC (c-Myc) were also genes with the most STRING connections from our study, partly reflecting the volume of research around these factors. The ERK MAP kinase pathway has . Recently, ERK1/2 signaling was found to be involved in the regulation of hypertrophic changes of normal articular cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts 44 . MYC expression in OA cartilage correlates with apoptosis of the chondrocytes 45 . ATF3 (activating transcription factor 3) also featured strongly in both our IPA and STRING analyses. ATF3 is a transcription factor induced by various stress signals and proposed to be a hub of the cellular adaptive-response network 46 . ATF3 down-regulation adds support to the hypothesis that OA chondrocytes becomes less responsive to stimuli 47 . Pain in OA is complex and poorly understood, but recently ATF3 has been used as a marker of nerve injury in lumbar (L)4 and L5 dorsal root ganglia of the ipsilateral knee in a rat knee OA model 48 . Both
GADD45a and GADD45b also featured in the down-regulation STRING analysis with both having been previously identified as down-regulated in OA cartilage as part of a microarray analysis. GADD45b has been proposed to play a role in chondrocyte homeostasis via the regulation of collagen gene expression and the promotion of cell survival 17 . Herein we also compared gene expression differences between hip and knee OA, providing lists of genes and molecular pathways common to both disorders. Common between the two tissues was an increase in a large number of ECM-associated genes, especially collagens, purportedly as an ineffectual repair response 49 . Similar increases in matrix genes with OA have been reported by others 18 .
Importantly, this work also highlights gene differences between OA in both tissues. A clear difference in the hip and knee datasets is present when examining the expression of metalloproteinases. The expression of the collagenase gene MMP-1 and the aggrecanase gene ADAMTS-5, along with ADAMTS1, were all increased in knee OA cartilage but decreased in hip OA cartilage, an observation that has been reproducibly observed 8e10 . This could suggest the disease mechanisms are fundamentally different, reflect the stage of disease at which hip or knee replacement surgery occurs, or be due to the normal comparator group, healthy tissue 20 or NOF fracture herein. In a preliminary study, gene expression within NOF fracture or post-mortem was largely similar, validating the use of NOF as a control tissue 9 . The OA femoral tissue used within this study was end-stage disease with significant cartilage damage, as exemplified by the high score using the modified Noyes system 22 . However, we only examined gene expression in macroscopically normal cartilage taken from the OA patients, yet significant gene expression differences were observed between this cartilage and the NOF control tissue. This finding supports the concept that even OA cartilage tissue of healthy macroscopic appearance is not necessarily free of disease 18 . The OA tissue used was taken from patients undergoing joint replacement surgery therefore the gene expression herein will likely be distinct from those occurring at initiation or during disease progression. The relatively small number of overlapping differentially expressed genes between our hip and the knee OA studies may reflect a difference in the tissues or the analysis undertaken 50 . However, even taking this into consideration, a remarkable number of pathways appeared to be conserved features of the disease in both tissues. These included 'Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis' and 'Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis' perhaps unsurprisingly given their link to arthritis, and Wnt/b-catenin, IL-8 and IL-17 Signaling. However, 'Oncostatin M Signaling' contained the highest proportion of differentially expressed genes within a given pathway (approximately 21%). Oncostatin M in combination with other proinflammatory cytokines has been extensively linked to the induction of metalloproteinases by chondrocytes 51 . 'triggering receptor expressed on myeloid cells (TREM)1 signaling' also contained a high proportion of differentially expressed genes from both tissue gene lists. TREM proteins are a family of cell surface receptors that participate in diverse cell processes including inflammation, where they act in concert with other receptors to amplify an inflammatory response, and bone homeostasis where they play a role in osteoclastogenesis 52 . The role of TREM signaling in chondrocytes and cartilage remains to be determined, though TREM-1 is up-regulated in RA synovium 53 and is proposed as a new therapeutic target in the disease 54 . A number of pathways associate only with hip OA cartilage including pathways connected with proteoglycans 'Glycosaminoglycan Degradation' and 'O-Glycan Biosynthesis' and more novel pathways such as 'Circadian Rhythm Signaling'. Knee OA specific pathways included 'IGF-1 Signaling' and 'Ephrin Signaling', both of which have established links with the disease or chondrocytes 55, 56 .
In conclusion, to our knowledge this is the first study to compare gene expression changes in osteoarthritic femoral hip cartilage to that of patients with no signs of OA at the whole-genome level. These data have identified a number of novel pathways, such as IL-17 signaling along with a number of genes that appear integral to signaling, including CCL20 and MAPK1, and subsequent responses, such as ATF3, all of which may have a role in OA pathogenesis. Importantly, by comparing gene expression changes between hip and knee OA both commonality, such as the 'TREM1 signaling pathways', and discord such as the 'O-Glycan Biosynthesis' in hip and 'IGF-1 signaling' in knee OA are observed. Although proteolytic loss of cartilage typifies OA 57 in both hip and knee joints, our observations add to the notion that the molecular mechanisms underpinning such destruction may have some unique and specific differences. Exploitation of these may proffer the potential for more tailored, joint-specific therapies that circumvent the negative aspects associated with direct metalloproteinase inhibition 57 . . Green points indicate genes that are significantly differentially expressed in the same direction (up-or down-regulated in OA) in both studies. Red points indicate genes that are regulated in the opposite direction. N, number of genes in each quadrant. Despite the large discrepancy in differentially expressed genes, the fold changes of these overlapping genes are significantly co-related. (D), Sizedependent Venn diagram of the pathways identified as associated with the differentially expressed knee and hip OA gene lists. Approximately half of the pathways associated with our differentially expressed gene list for hip were also identified in the knee OA study indicating that, although the gene lists are largely different between joints, many of the same pathways are involved in OA.
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